Pharmalive - The Pulse of the Pharmaceutical Industry


Search Criteria: Search In:  
Conferences
  
ARCHIVE
1999 | 2000 | 2001 |
2002 | 2003 | 2004 |
2005 | 2006 | 2007 |
2008 | 2009 | 2010


 
 
The creation of transformative leaders back to table of contents  
  To find out what it takes to be a leader who can recognize a need and then take an organization in a new direction, Med Ad News spoke with Kim Palmisano and Karen Addison of the Center for Creative Leadership (ccl.org).

by Steven Niles

Ask The Experts

MedAdNews
What are the main takeaways you had from the FDA hearings on social media ...
Asia is a rapidly growing market with deep traditional roots, so is this geographic ...
As I manage a community outreach program for a large hospital, I observe how ...

R&D Directions
Are there any ways to ameliorate the cardiac risks of a drug in development, if such ...
Do you see a discernable increase in demand for formulation development services ...
What are the one or two, in your opinion, most promising novel imaging techniques ...

Podcasts

The MedAdNews Show
Episode 1: Tax Terror
Download

Webcasts

MedAdNews
Promotional Effectiveness with the Physician, Pharmacy, and Patient
Wednesday, March 3, 2010 2PM – 3PM EST
Register

Views on Patient Adherence
Tuesday, January 12, 2010 2:00 PM EDT
View Webinar

Improving Compliance Through Master Data Management and an Aggregate Spend Solution
Monday, September 21, 2009 2:00 PM EDT
View Webinar

R&D Directions
Investigator Site Solutions for Clinical Trials
Thursday, September 17, 2009
View Webinar

Mergers & Acquisitions, Partnerships, & Collaborations 2010 – Review and Outlook

This PharmaLive Special Report analyzes the healthcare industry’s M&As of 2009, providing a comprehensive listing of companies’ M&A activity and detailing the top 20 deals within each of the Pharmaceutical, Biotechnology, Specialty, and Medical Device sectors, and previews potential M&A activity within the healthcare arena for 2010.

The introductory rate of $395 expires February 17, 2010.

Learn More

Med Ad News: Tell me a little about the Center for Creative Leadership.

Kim Palmisano: We are an executive education provider, top 10 in the world ranked by the financial times, and we help clients worldwide cultivate creative leadership. The way we define that is the capacity to achieve more than imagined by thinking and acting beyond boundaries. Since our inception, we have over 400,000 participants graduate from our open enrollment programs each year. We’re a unique center for business education that combines the research of behavioral science with practical, real-world business application.
We work with about two-thirds of the Fortune 500 companies, 80 of the Fortune 100 companies are our clients, and every year we work with about 3,000 organizations from a 120 countries across the 4 different continents.

Med Ad News: What percentage of those clients are in the pharma industry or in related areas?

Kim Palmisano: The percentage, I couldn’t say, but I can tell you that we work with more than 70 pharmaceutical and biotech organizations.

Med Ad News: What does it take to be someone who can recognize a need and then lead the organization or division in a new direction to address that need?

Kim Palmisano: We at CCL believe that it takes the realization that our success of the past is no longer the formula for how things must be done in the future. That it takes a greater inner reflection on how I, as the individual, personally need to change, and it’s less of an absolute reliance on my manager and my company president to show the way to success.

Karen Addison: Our research shows interdependence leadership is the wave of the future, so it’s no one leader that can do it anymore, but it’s how that leader manages relationships with others and can bring together a leadership team and culture in the organization.

Med Ad News: So that requires finding like-minded individuals or can they instill that thought process in others?

Karen Addison: It’s our philosophy as a center that leadership can be learned, and so it’s a matter of developing your people, but its also recognizing you can’t do it on your own. The days of that kind of one fearless leader out in the front are behind us, and it’s much more of a networked approach to leadership that’s going to take organizations forward.

Kim Palmisano: We realized that today the challenges that we’re facing are just more complex than ever before and that these challenges, these events that these challenges are bringing forth, the complexity of them, are requiring leaders to react and interact and behave in new and different ways. And what we mean by that is it’s important to develop your leadership agility and adaptability along with the intuitive ability to make decisions. Those are the key competencies that we talked about here. And that’s going to lead to success for the organizations to be able to go in new directions.

Med Ad News: Could you get into specifics at all how that actually is done? How do you teach that?

Karen Addison: What we try and work with is having people bring their own issues to the classroom. We have an exercise called a Key Leadership Challenge, so when I come to the program, any number of programs, but particularly our custom programs, I bring with me a challenge within my organization over which I have some control that I can’t solve on my own that may have been there for awhile and is so complex in nature that maybe we’ve never had solutions to that problem before, because we’ve not had that problem before. And we use that as a foundation for their time with us and say what is it that I learned about communication, what is it that I learned about strategy versus tactics, what is it I learned about myself and the diversity in my work place so that I can leverage that diversity to meet these challenges and keep it anchored in what they’re facing on a day-to-day basis.

Med Ad News: As they bring these problems in to address, have you seen any trends in what people are saying? In what kinds of challenges they’re facing and what they need to deal with?

Kim Palmisano: Yes. The issues are more complex today. We did a 10 Trend study in 2007, and it supports the idea that what has worked in the past no longer works in the future and what we have found that the executives that we talk to in that study have felt only 50% of their organizations were topping class in innovation, so that’s especially relevant to the pharmaceutical industry.
They also confirmed that the challenges that they are facing today are more complex than they were just five years ago. When we ask them what contributed to this complexity, the top three answers were internal changes – structure and process – marketing and dynamics, and talent shortage.

Karen Addison: I just finished a program with Bayer, and the change theme was enormous with that group of leaders. In the pharmaceutical industry right now, with all the mergers and acquisitions, change is not just process but there’s cultural change that has to take place. Who’s in charge kind of change that has to take place? How do you create new values that work for both sets of people who may have had very different cultural values in the past?

Med Ad News: In the trends we’re seeing there’s a shift in the growing importance on biotechnology and specialty medicine. Have you been seeing clients come in with this type of issue and is there a different type of leader needed to lead a biotech versus a traditional pharma company?

Kim Palmisano: Being innovative and working collaboratively on those particular dynamics is what’s key today, and we know that to work collaboratively no longer means communicating well and working with others. It’s about a focus of getting a new product to market or working with ownership and accountability as a team member as a part of an organization so that you are moving forward for the success of the end goal.
So we have learned that working collaboratively with trust, getting rid of the me factor of getting the credit. It’s a trust factor, it’s taking ownership of yourself as part of a member of the team that has a common goal. And working in that way for new innovation.

Karen Addison: And recognizing that team may cross boundaries that in the past created silos in the organization or were such that we’re not going to collaborate with that group or we don’t really need input from this group of people. But they do, and they’re finding out that they do.

 



Want access to all Med Ad News articles on PharmaLive.com?

You can access all premium content and more with a paid subscription to Med Ad News - providing you with a distinct knowledge advantage. Click here for details.

If you have a paid subscription, click here to login or register for access to premium content.



Printer Friendly Version
Want to use this article? Click here for options!
Copyright © 2010 PharmaLive.com


back to top..

 
©2010 Canon Communications Pharmaceutical Media Group